Ibogaine-Assisted Therapy

Set and setting are essential

For ibogaine, setting includes the medical infrastructure around you. Alongside emotional safety and trust, treatment requires a properly equipped clinical environment, qualified medical staff and continuous cardiac monitoring. Ibogaine's particular effects on heart rhythm make this level of care central to treatment.

Set includes your emotional state, intentions, expectations, personal history and current circumstances. Preparation gives you time to build trust, discuss what may emerge and understand how you will be supported.

Setting combines a calm, nurturing environment with substantial medical capability. Continuous heart monitoring, regular vital-sign checks, IV access and staff equipped to respond to medical emergencies are important elements of medically supervised ibogaine care. Monitoring needs to continue into recovery, with its duration determined by the clinical team.

The room can feel comfortable and supportive while also being equipped for clinical care. Emotional warmth, clear consent and respectful therapeutic support remain important throughout.

The medical care and the human care belong together. Feeling heard, respected and supported matters during an experience that can leave someone physically and psychologically vulnerable.

What does treatment involve?

Ibogaine treatment involves several stages of medical assessment, preparation, monitored treatment and recovery. The details should be tailored to the individual, with medical clearance required before dosing.

Assessment before arrival

Assessment begins with a detailed review of physical and mental health, medications, supplements and substance use. Clinicians also consider cardiac history, previous fainting, family history of sudden cardiac death and any withdrawal-related needs.

Screening includes a current 12-lead ECG and blood tests. Further cardiac assessment, such as an echocardiogram or specialist review, may be required depending on medical history and initial findings.

An ECG, also called an EKG, measures the heart's electrical activity and helps identify rhythm concerns, including a prolonged QT interval. An echocardiogram uses ultrasound to assess the heart's structure and function.

Blood work should assess electrolytes, including potassium and magnesium, alongside liver and kidney function. These results help clinicians understand factors that may affect treatment suitability and the body's ability to process the medicine.

Medical checks on arrival

Pre-arrival approval does not replace an on-site assessment. The clinical team needs to confirm current health, review test results, check vital signs and establish whether additional or repeat testing is necessary.

An up-to-date ECG and blood results should be reviewed before treatment clearance. Substance testing may also form part of assessment where relevant to interactions or withdrawal management. Treatment may need to be delayed if findings require further investigation or stabilisation.

Preparation and medical readiness

Preparation includes understanding the experience, building trust and planning for support afterwards. There should be space to discuss intentions, fears, expectations and how difficult emotions will be supported.

Medical readiness also needs to be established. Clinicians assess hydration, electrolyte balance, medications and any withdrawal-related needs, correcting identified problems where appropriate. Medication changes and withdrawal management must be directed by the responsible clinician.

The monitored medicine session

During treatment, continuous cardiac monitoring allows clinicians to observe heart rate, rhythm and changes in the QT interval, the time the heart's electrical system takes to recover between beats. Blood pressure, oxygen levels, breathing and other vital signs also require observation.

An IV line provides access for clinically indicated fluids, electrolytes and emergency medication. It does not necessarily mean ibogaine itself is given intravenously. The fluid and electrolyte plan should be individualised by the medical team. Published ibogaine guidance recommends maintaining IV access until the physician considers the cardiac risk to have passed.

Qualified medical staff should remain available throughout, with resuscitation equipment and a clear emergency-transfer plan. The team also supports comfort, emotional wellbeing and practical needs during the experience.

Recovery and repeat assessment

Care continues after the main experience. Feeling mentally clearer does not by itself establish that someone is medically ready to leave monitoring.

Repeat ECGs, blood testing and clinical assessment may be needed to review heart rhythm, electrolyte balance and recovery. Research protocols describe extending cardiac monitoring when abnormalities persist, with further decisions made by the medical team.

Integration and follow-up

Once medically stable, the focus shifts towards rest, processing the experience and building ongoing support. That may involve trauma therapy, somatic approaches, addiction care or practical changes in everyday life.

Screening, monitoring, recovery and integration are all part of the treatment. They help make an intensive experience more supported, while recognising that even thorough medical care cannot eliminate every risk.